Philip Morris
the Manipulation of Genes
Fields
- Author
- Cohen, S.N.
- Type
- PSCI, SCIENTIFIC PUBLICATION
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH
- PHOT, PHOTOGRAPH
- BIBL, BIBLIOGRAPHY
- Area
- WAKEHAM,HELMUT/KAROL SHARPE'S OFFICE
- Site
- R37
- Named Organization
- Asilomar Conference Center
- Boyers Lab
- Natl Academy of Sciences
- Rutgers Univ
- Stanford Univ School of Medicine
- Univ of California
- Univ of Edinburg
- Univ of Hawaii School of Medicine
- Univ of Pennsylvania School of Medi
- Univ of Wisconsin
- Wh Freeman
- Albert Einstein College of Medicine
- Boyers Lab
- Named Person
- Berg, P.
- Boyer, H.W.
- Chang, Acy
- Clowes, R.C.
- Davis, R.W.
- Goodman, H.M.
- Helling, R.B.
- Higa, A.
- Hsu, L.
- Jackson, D.
- Kaiser, A.D.
- Khorana, H.G.
- Lobban, P.
- Mandel, M.
- Mertz, J.
- Morrow, J.F.
- Sgaramella, V.
- Symons, R.
- Watanabe, T.
- Yoshimori, R.N.
- Boyer, H.W.
- Request
- Stmn/R1-004
- Stmn/R1-150
- Author (Organization)
- Scientific American
- Master ID
- 1000229536/9811
Related Documents:- 1000229537-9544
- 1000229545-9550 Brief Synopsis
- 1000229551-9552 Introduction
- 1000229553-9555 Brief History of Cetus Financing
- 1000229556-9557
- 1000229558-9560 Special Note to Investors
- 1000229561-9563 Special Note Regarding Founder's Stock
- 1000229567-9569 Board of Directors
- 1000229575-9580 Achievements of Cetus People
- 1000229581-9599 Present Cetus Activities
- 1000229600-9616 Research Plan
- 1000229617-9619 Patents
- 1000229621-9656 Debenture Purchase Agreement
- 1000229657-9661 the Cetus Story
- 1000229663-9667 Cloning Business: It's Growing Fast It's Growing Fast
- 1000229668 World Roundup
- 1000229669-9670 Latin Drive: Brazil Spends Millions to Put Alcohol in Cars and Save Oil
- 1000229671 Can US Reduce Imports with Gasoline? Some Say Yes, But Officials Are Dubious
- 1000229672-9673 Bacterial Insulin Production Hears Reality
- 1000229674 Business World
- 1000229675-9677 Who Should Play God?
- 1000229678 Schering Plough New York Analysts' Meeting December 7, 1977
- 1000229679 Indiana Standard Labels Purchase Offer Part of Move to Wider Technology Base
- 1000229680 Big Deal for Berkley Bugs
- 1000229681 Oil-Less World May Run on Bugs
- 1000229682-9685 Tinkering with Life
- 1000229686-9687 Set for Biology's New Revolution
- 1000229688 Little Black Box of Cetus
- 1000229689-9695 Industry Is Finding More Jobs for Microbes
- 1000229696-9701 Dup of Id 1000229657-9661
- 1000229702-9710 Recombinant Molecular Research at Cetus Corporation
- 1000229711-9715 New Cetus Antibiotic
- 1000229716-9720 Letter to the Shareholders
- 1000229721-9726 Letter to Shareholders
- 1000229727-9728 Letters to the Shareholders
- 1000229729-9730
- 1000229731-9734 Letter to the Shareholders
- 1000229735-9736 Letter to Shareholders
- 1000229750-9770 Microbial Genetics and the Future of the Pharmaceutical Industry
- 1000229771-9774 Recombinant Dna: Fact and Fiction
- 1000229775-9778 Testomony of Ronald E Cape, Phd President, Cetus Corporation, Berkeley, California Before the House Subcommittee on Science, Research and Technology
- 1000229779-9797 Biosystems Poised for Growth
- 1000229798-9805 Testimony of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkley, California Before the Senate Subcommittee on Science, Technology and Space
- 1000229806-9807 Statement of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkeley, California Before A Special Joint Congressional Hearing in Conjunction with Oversight Hearings on Science and Technology Policy the Senate Subcommittee on Science, Technology and Space of the Commerce, Science and Transportation Committee Presiding, Senator Adlai Stevenson, III Washington, Dc
- 1000229808-9811 Statement of Ronald E. Cape, Ph.D. President, Cetus Corporation, Berkeley, California at the Annual Meeting of the American Association for the Advancement of Science Session on Recombinant Dna Public Health and Biomedical Research Policy Washington, D.C.
- Litigation
- Stmn/Produced
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- dgo74e00
Document Images
pect of constructing bacterial cells,
which can be grown easily and inexpen-
sively, that will synthesize a variety of
biologically produced substances such as
antibiotics and hormones; or enzymes
that can convert sunlight directly into
food substances or usable energy. Per-
haps it even provides an experimental
basis for introducing new genetic infor-
mation into plant or animal cells.
It has been clear from the beginning of
experimentation in molecular cloning
that the construction off some kinds of
novel gene combinations may have a po-
tential for biological hazard, and the sci-
entific community has moved quickly to
make certain that research in genetic
manipulation would not endanger the
public. For a time after our initial experi-
ments the pSC101 plasmid was the only
vehicle known to be suitable for cloning
foreign DNA in E. coli, and our col-
leagues asked for supplies with which to
pursue studies we knew were of major
scientific and medical importance. In-
vestigators normally facilitate the free
exchange of bacteria and other experi-
mental strains they have isolated or de-
veloped, but Chang and I were con-
cerned that manipulation of certain
genes.could give rise to novel organisms
whose infectious properties and ecologi-
eal effects could not be predicted. In
agreeing to provide the plasmid we
therefore asked for assurance that our
colleagues would neither introduce tu-
mor viruses into bacteria nor create anti-
biotic-resistance combinations that were
not already present in nature; we also
asked the recipients not to send! the plas-
mid on to other laboratories, so that we
could keep track of its distribution.
When still other cloning vehicles were
CLEAVED TOAD
RIBOSOMAL DNA
discovered, it became apparent that a
more general mechanism for ensuring ex-
perimental safety in gene-manipulation
research was advisable. The groundwork
for such control had been established
earlier: the National Academy of Sci-
ences had been urged to consider the
"possibility that potentially biohazardous
consequences might result from wide-
spread or injudicious use" of these tech,
niques and had asked Paul Berg to form
an advisory committee that would con-
sider the issue. Berg too had been con-
cerned about the potential, hazards of
certain kinds of experimentation for
some years, and had himself decided to
abandon plans to try to introduce genes
from the tumor virus SV40 into bacteria
because of the possible danger if the ex-
periment were successful.
Berg brought together a number of i4-
vestigators, including some who were
then directly involved in molecular clon-
ing, in the spring of 1974. In a report
released in July and in a letter to leading
professional jpurnals the members of
the committee expressed their "concern
about the possible unfortunate conse-
quences of indiscriminate application"
of the techniques and formally asked all,
investigators to join themi in voluntarily
deferring two types of experiments
(which had, as a matter of fact, been
avoided by informal consensus up until
that time). Experiments of Type I in-
volved the construction of novel orga-
nisms containing combinations of toxin-
producing capabilities or of antibiotic-
resistance genes not found in nature.
Type 2 experiments involved the intro-
duction of DNA from tumor viruses or
other animal viruses into bacteria; the
committee noted'~ that "such recombinant
molecules might be more easily dissemi-
CD 42
CLEAVED PLASMID CHIMERAS
nated to bacterial populations in humans
and other species, and might thus in-
crease the incidence of cancer or other
diseases."
The Academy committee was con-
cerned largely because of our inability
to assess the hazards of certain experi-
ments accurately before the experiments
were undertaken. Guidelines for safety
had long been available in other areas of
potentially hazardous research, such as
studies invol+ving known disease-causing
bacteria and viruses, radioactive isotopes
or toxic chemicals. Because of the new-
ness of the microbial gene-manipulation
methods, no such guidelines had yet
been developed for work in this area,
however; there was the possibility that
potentially hazardous experiments might
proceed before appropriate guidelines
could be considered and implemented.
We recognized that most work with the
new methods did not and would not in-
volve experiments of a hazardous nature
but we recommended the deferral of '
Type I and Type II experiments until the
hazards were more carefully assessed,
until it was determined whether or not
the work could be undertaken safely and
until adequate safety precautions were
available. The committee also proposed
that an international meeting be held
early in 1975 to consider the matter more
fully:
Such a meeting was held in February
at the Asilomar Conference Center near
Pacific Grove, Calif. It brought together
86 American biologists and 53 investiga-
tors from 16 other countries, who spent
three and a half days reviewing progress
in the field of molecular cloning and for-
mulating guidelines that would allow
most types of new hereditary character-
istics to be introduced into bacteria and
CD30 CD35 CD4
CD 18
-4.2
-3.9
4
/
GEL ELECTROPHORESIS demonstrates the presence of toad
DNA in chimeric plasmids. Fragments of DNA migrate through a
gel at different rates under the influence of an electric current, de,
pending on their size. Linear molecules of plasmid DNA (right)
and the cleavage products of toad ribosomal DNA (Te/t) therefore
10
3.0
have characteristic sizes and migrate characteristic distances in a
given time. The bands of DNA, visualized by a fluorescent dye, are
photographed in ultraviolet. All five chimeric plasmids (center)
contain a plasmid DNA molecule; in addition each chimera in-
cludes one or more fragments characteristic of original toad DNA.
CLEAVED
pSClot
PLASMID
c

~_ viruses safely: Invited nonscientists from
the fields of law and ethics participated
in the discussions and decisions at Asilo-
mar, along with representatives of agen-
cies that provide Federal funds for sci-
entific research; the meetings were open
to the press and were fully reported. The
issues were complex and there were wide
differences of opinion on many of them,
but there was consensus on three major
points. First, the newly develope& clon-
ing methods offer the prospect of deal-
ing with a wide variety of important sci-
entific and medical problems as well as
other problems that trouble society, such
as environmental pollution and food and
energy shortages. Second, the accidental
dissemination of certain novel biological
combinations may present varying, de-
grees of potential risk. The construction
of such combinations should proceed
only under a graded series of precau-
tions, principally biological and physical
barriers, adequate to prevent the escape
of any hazardous organisms; the extent
of the actual risk shoul& be explored'by
experiments conducted under strict con-
tainment conditions. Third, some experi-
ments are potentially too hazardous to
be carried out for the present, even with
the most careful containment. Future re-
search and experience may show that
many of the potential hazards considered
at the meeting are less serious and less
probable than we now suspect. Never-
theless, it was agreed that~ standards of
protection should be high~ at the begin-
ning and that they can be modified later
if the assessment of risk changes.
Physical containment barriers have
long been used in the U.S. space-explo-
ration program to minimize the possibil-
ity of contamination of the earth by ex-
traterrestrial microbes. Containment pro-
cedures are also employed routinely to
protect laboratory workers and the pub-
lic from hazards associated with radio-
active isotopes and toxic chemicals and
in work with disease-causing bacteria
and viruses. The Asilomar meeting for-
mulated the additional concept of bio-
logical barriers, which involve fastidious
. cloning vehicles that are able to propa-
c
gate only in specialized hosts and equal-
ly fastidious bacterial, strains that'~ are
unable to live except under stringent
laboratory conditions.
In the past the scientific community
has commonly policed its own actions in-
formally, responding to ethical concerns
with self-imposed restraint. Usually, but,
not always;,society at large has also con-
sidered the public well-being in deter-
mining how knowledge: obtained by
basic scientific research should be ap-
plied. Extensive public scrutiny and
TOAD DNA
.
HETERODUPLEX ANALYSIS identifies regions of a toad DNA (black) that have been in-
corporated in a chimeric plasmid DNA molecule. DNA isolated from toad eggs and the
DNA of the chimera are denaturedthat is, each natural double-strand molecule is split into
two single strands of DNA, by alkali treatment. The toad and the cbimeric DNA's are mixed
together, and any complementary sequences are allowed to find each other. The toad DNA
incorporated in the chimeras has nucleotide sequences that are complementary to sequences
in the DNA taken directly from the animal source. Those homologous sequences anneal
to form heteroduplex double-strand DNA..t6at can be identified in electron micrograpbs.
open discussion by scientists andd non- lic discussions initiated by scientists
scientists of the possible risks and bene- working in genetic manipulation will be.
fits of a particular line of basic research One can hope that the forthright ap-
has been rare, however, when (as in this proach and the rigorous standards that
case) the hazards in question are only have been adopted! for research in the
potential and; for some experiments, cloning of recombinant DNA molecules
even hypothetical. As this article is be. will promote a sharper focus on other
ing written it is still'too early to know issues relevant to public and environ-
what the long-range outcome of the pub- mental safety.
PRESENCE OF'TOAD DNA in two separate chimeric plasmid molecules is demonstrated
by an electron micrograph made by John F. Morrow at the Stanford University School of
Medicine. As is indicated in the drawing (bottom), there are DNA strands from two plas-
mids and a strand of toad DNA. The micrograph shows thickened regions of DNA where
nucleotide sequences are homologous and two single strands have been annealed. The
toad DNA in the chimeras cddes for ribosomes, and the space between the two betero-
duplex regions is compatible with the spacing of multiple ribosomal genes in toad DNA.
II
PLASMID DNA1ll1CKING

The Author
STANLEY N. COHEN is associate
professor of medicine at the Stanford
University School of Medicine. A gradu-
ate of Rutgers University and the Uni-
versity of Pennsylvania School of
Medicine, he joined the Stanford faculty
in 1968 after spending several years
teaching and doing research in molecular
biology at the Albert Einstein College of
Medicine. His research has also involved
a stint at'the National Institute of Arthri-
tis and Metabolic Diseases. A specialist
in bacterial plasmids, Cohen was a mem-
ber of the National Academy of Sciences
committee that recently callod' for the
voluntary deferral of' certain potentially
hazardous experiments involving recom-
binant DNA molecules.
Bibliography
CONSTRUCTION' OF BIOLOGICALLY
FUNCTIONAL BACTERIAL PLASMIDS IN'
VITRO. Stanley N. CohenAnnie C. Y.
Chang, Herbert W. Boyer and'Robert
B. Helling in Proceedings of the Na-
tional Academy o f Sciences o f the
United States of America, Vol. 70,
No. 11, pages 3240-3244; November,
1973.
REPLICATION AND TRANSCRIPTION OF
EUxARYoTIc DNA IN ESCHERICHIA
COLI. John F. Morrow, Stanley N.
Cohen, Annie C. Y. Chang, Herbert
W. Boyer, Howard M. Goodman and
Robert B. Helling in Proceedings of
the National Academy o f Sciences o f
the United States of America, Vol. 71,
No. 5, pages 1743-1747; May, 1974.
POTENTIAL BIOHAZARDS OF RECOMBI~
NANT DNA MOLECULES. P. Berg et al.
in Proceedings of the National Acad-
emy of Sciences of the United States
of America, Vol. 71, No. 7, pages
2595-2599; July, 1974.
FIRST ASM CONFERENCE ON E%TRA-
CIiROMOSOMAL ELEMENTS IN BACTE-
RIn in Microbiology-1974. American.
Society for Microbiology, 1975.
REPORT OF TIIE WORKING' PARTY ON
THE EXPERIMENTAL MANIPULATION
OF MICROORGANISMS. Her Majesty's
Stationery Office, London;1975.
